许培扬博客分享 http://blog.sciencenet.cn/u/xupeiyang 跟踪国际前沿 服务国内科研

博文

研究热点:雷帕霉素靶蛋白(mTOR)、磷酸肌醇3激酶(pi3k)信号通路

已有 4713 次阅读 2013-5-8 09:04 |个人分类:热点前沿|系统分类:科研笔记| 蛋白, 通路, 肌醇

       利用汤森路透科技集团的基本科学指标库(Essential Science Indicators)2004-2010间的高被引论文及其同被引聚类分析,通过同被引而密切关联的相关论文聚类形成若干个科学研究领域,由此绘制科学文献所反映的科学研究结构地图,讨论科学发展的基本格局。通过研究和揭示科学结构及其演化,为各领域研究提供一种思考问题、发现潜在交叉学科、“热点”领域。

/******************************************************************/

                    第一部分:RA 10  的基本信息

/******************************************************************/

 

RA ID: 10

RA的名称

雷帕霉素靶蛋白(mTOR)、磷酸肌醇3激酶(pi3k)信号通路与疾病发生的关系

RA的关键词

mammalian target; pik3ca gene; protects against age- and diet-induced obesity while enhancing insulin sensitivity; pathway activation through a pi3k-dependent feedback loop in human cancer; rictor-mtor complex integrity and regulates akt phosphorylation and substrate specificity; mapk pathway activation through a pi3k-dependent feedback loop in human; sin1/mip1 maintains rictor-mtor complex integrity and regulates akt phosphorylation and; s6k1 protects against age- and diet-induced obesity while enhancing insulin; maintains rictor-mtor complex integrity and regulates akt phosphorylation and substrate; ras/erk signaling promotes site-specific ribosomal protein s6 phosphorylation via rsk

包含RF(Hot RF)

核心论文数

被引用篇数

总被引次数

平均出版年

9(4)

74

3792

8792

2006.7

RA中包含RF的图谱

核糖体蛋白S6激酶磷酸化的调节作用

mTORC1mTORC2、氨基酸对mTOR的调控机制、mTORakt/makp信号通路的调节

RA概述

雷帕霉素(Rapamycin)自20世纪70年代开发出来便经常作为免疫抑制剂用于器官移植,以减缓器官移植手术后的免疫排斥反应,特别是肾移植。雷帕霉素的涂层支架已为成千上万的冠心病患者解决了冠脉支架植入后的再狭窄问题,此外,新近发现雷帕霉素相关产品还是许多癌症治疗的重要靶向药物的选择。雷帕霉素靶蛋白(mTOR)作为细胞内激酶,是高分子量丝氨酸-苏氨酸激酶、磷酸肌醇3-激酶(PI3K)相关激酶(PIKK)的家族成员。近几年的研究发现mTOR传导通路的异常也可以诱发许多疾病。mTOR信号通路在神经疾病和抗衰老、炎症性疾病、纤维化疾病、肺动脉高压等诸多领域研究活跃,具有无限的市场应用前景。而对mTOR进行抑制便成为治疗与该通路密切相关的肿瘤包括肾癌、淋巴瘤、肺癌、肝癌、乳腺癌、神经内分泌癌和胃癌等的靶点所在。

 

 

/******************************************************************/

           第二部分:RA 10 包含的9RF的基本信息

/******************************************************************/

 

RF ID: 6247

核心论文数

被引用篇数

总被引次数

平均出版年

是否为热点

25

1434

3625

2007.5

Yes

RF的关键词

mtor-mediated translational control molecular mechanisms; mtor complex 2 (mtorc2) controls hydrophobic motif phosphorylation; intact mtor signaling complex 2; pras40 regulates mtorc1 kinase activity; mammalian tor complex 2 controls

RF ID: 6714

核心论文数

被引用篇数

总被引次数

平均出版年

是否为热点

20

987

2012

2007.3

No

RF的关键词

mtor/phosphatidylinositol 3-kinase inhibitor nvp-bez235 lapatinib resistance reversal; vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug; pi 3-kinase p110 beta

RF ID: 8254

核心论文数

被引用篇数

总被引次数

平均出版年

是否为热点

11

900

2120

2005.5

No

RF的关键词

oncogenic pi3k alpha mutations; phosphatidylinositol 3-kinase mutations identified; human breast cancers; human p110 alpha/p85 alpha complex elucidates; pik3ca mutations correlate

RF ID: 11354

核心论文数

被引用篇数

总被引次数

平均出版年

是否为热点

5

387

817

2005.0

No

RF的关键词

amino acid mtor/raptor signaling class-3 phosphatidylinosital 30h-kinase mediation; nutrient-regulated lipid kinase required; mammalian target; amino acid sufficiency; p70 s6 kinase

RF ID: 13303

核心论文数

被引用篇数

总被引次数

平均出版年

是否为热点

3

505

849

2004.0

No

RF的关键词

tsc/rheb/mtor/s6k cassette inappropriate activation induces irs1/2 depletion-insulin resistance-cell survival deficiencies; enhancing insulin sensitivity; insulin resistance; tsc1-2 tumor suppressor controls insulin-p13k signaling

RF ID: 14863

核心论文数

被引用篇数

总被引次数

平均出版年

是否为热点

3

315

405

2005.6

No

RF的关键词

ras/erk signaling; site-specific ribosomal protein s6 phosphorylation; mitogen-activated protein kinase-dependent s6 kinase pathway; protein synthesis; rapamycin-sensitive 5 ''-terminal oligopyrimidine mrna translation

RF ID: 9782

核心论文数

被引用篇数

总被引次数

平均出版年

是否为热点

3

395

574

2006.0

Yes

RF的关键词

mtor inhibition induces upstream receptor tyrosine kinase signaling; rapamycin induces feedback activation; akt signaling; rapamycin inhibition; activates akt

RF ID: 7986

核心论文数

被引用篇数

总被引次数

平均出版年

是否为热点

2

72

120

2008.0

Yes

RF的关键词

erk mapk signaling; hormone-refractory prostate cancer; mapk pathway activation; human cancer; pi3k-dependent feedback loop; preclinical mouse model

RF ID: 12550

核心论文数

被引用篇数

总被引次数

平均出版年

是否为热点

2

70

108

2008.0

Yes

RF的关键词

oncogenic cellular transformation; class ipi3k; pi3k/akt pathway; cancer; drug discovery

 

 

/******************************************************************/

          第三部分:9RF的核心论文详细列表

/******************************************************************/

 

RF ID

核心论文数

被引用篇数

总被引次数

平均出版年

是否为热点

6247

25

1434

3625

2007.5

Yes

RF的关键词

mtor-mediated translational control molecular mechanisms; mtor complex 2 (mtorc2) controls hydrophobic motif phosphorylation; intact mtor signaling complex 2; pras40 regulates mtorc1 kinase activity; mammalian tor complex 2 controls

 

论文题目

被引

年份

刊名

第一作者

第一机构、国家

phosphorylation and regulation of akt/pkb by the rictor-mtor complex

1007

2005

SCIENCE

SARBASSOV DD

MIT, USA

rictor, a novel binding partner of mtor, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton

457

2004

CURR BIOL

SARBASSOV DD

MIT, USA

prolonged rapamycin treatment inhibits mtorc2 assembly and akt/pkb

348

2006

MOL CELL

SARBASSOV DD

Whitehead Inst Biomed Res, USA

mammalian tor complex 2 controls the actin cytoskeleton and is rapamycin insensitive

315

2004

NAT CELL BIOL

JACINTO E

Univ Basel, Switzerland

sin1/mip1 maintains rictor-mtor complex integrity and regulates akt phosphorylation and substrate specificity

190

2006

CELL

JACINTO E

Univ Texas, USA

mtor center dot rictor is the ser(473) kinase for akt/protein kinase b in 3t3-l1 adipocytes

174

2005

J BIOL CHEM

HRESKO RC

Washington Univ, USA

ablation in mice of the mtorc components raptor, rictor, or mlst8 reveals that mtorc2 is required for signaling to akt-foxo and pkc alpha but not s6k1

164

2006

DEV CELL

GUERTIN DA

MIT, USA

pras40 is an insulin-regulated inhibitor of the mtorc1 protein kinase

141

2007

MOL CELL

SANCAK Y

MIT, USA

ampk phosphorylation of raptor mediates a metabolic checkpoint

130

2008

MOL CELL

GWINN DM

Salk Inst Biol Studies, USA

insulin signalling to mtor mediated by the akt/pkb substrate pras40

118

2007

NAT CELL BIOL

VANDER HAAR E

Univ Minnesota, USA

the rag gtpases bind raptor and mediate amino acid signaling to mtorc1

114

2008

SCIENCE

SANCAK Y

MIT, USA

msin1 is necessary for akt/pkb phosphorylation, and its isoforms define three distinct mtorc2s

93

2006

CURR BIOL

FRIAS MA

MIT, USA

regulation of torc1 by rag gtpases in nutrient response

66

2008

NAT CELL BIOL

KIM E

Univ Calif San Diego, USA

pras40 regulates mtorc1 kinase activity by functioning as a direct inhibitor of substrate binding

63

2007

J BIOL CHEM

WANG LF

Univ Virginia Hlth Syst, USA

active-site inhibitors of mtor target rapamycin-resistant outputs of mtorc1 and mtorc2

51

2009

PLOS BIOL

FELDMAN ME

Univ Calif San Francisco, USA

mtor complex 2 (mtorc2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (sgk1)

43

2008

BIOCHEM J

GARCIA-MARTINEZ JM

Univ Dundee, Scotland

molecular mechanisms of mtor-mediated translational control

41

2009

NAT REV MOL CELL BIOL

MA XJM

Genentech Inc, USA

mtor complex 2 is required for the development of prostate cancer induced by pten loss in mice

24

2009

CANCER CELL

GUERTIN DA

Whitehead Inst Biomed Res, USA

biochemical, cellular, and in vivo activity of novel atp-competitive and selective inhibitors of the mammalian target of rapamycin

21

2009

CANCER RES

YU K

Wyeth Res, USA

ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mtor)

20

2009

BIOCHEM J

GARCIA-MARTINEZ JM

Univ Dundee, Scotland

torc-specific phosphorylation of mammalian target of rapamycin (mtor): phospho-ser(2481) is a marker for intact mtor signaling complex 2

15

2009

CANCER RES

COPP J

Salk Inst Biol Studies, USA

rictor/torc2 regulates caenorhabditis elegans fat storage, body size, and development through sgk-1

15

2009

PLOS BIOL

JONES KT

Univ Calif San Francisco, USA

the pharmacology of mtor inhibition

7

2009

SCI SIGNAL

GUERTIN DA

Nine Cambridge Ctr, USA

differential requirement of mtor in postmitotic tissues and tumorigenesis

4

2009

SCI SIGNAL

NARDELLA C

Harvard Univ, USA

characterization of the intrinsic and tsc2-gap-regulated gtpase activity of rheb by real-time nmr

4

2009

SCI SIGNAL

MARSHALL CB

Univ Hlth Network, Canada

 

RF ID

核心论文数

被引用篇数

总被引次数

平均出版年

是否为热点

6714

20

987

2012

2007.3

No

RF的关键词

mtor/phosphatidylinositol 3-kinase inhibitor nvp-bez235 lapatinib resistance reversal; vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug; pi 3-kinase p110 beta

 

论文题目

被引

年份

刊名

第一作者

第一机构、国家

pten activation contributes to tumor inhibition by trastuzumab, and loss of pten predicts trastuzumab resistance in patients

394

2004

CANCER CELL

NAGATA Y

Univ Texas, USA

a pharmacological map of the pi3-k family defines a role for p110 alpha in insulin signaling

253

2006

CELL

KNIGHT ZA

Univ Calif San Francisco, USA

a dual pi3 kinase/mtor inhibitor reveals emergent efficacy in glioma

190

2006

CANCER CELL

FAN QW

Univ Calif San Francisco, USA

a functional genetic approach identifies the pi3k pathway as a major determinant of trastuzumab resistance in breast cancer

155

2007

CANCER CELL

BERNS K

Netherlands Canc Inst, Netherlands

insulin-like growth factor-i receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells

144

2005

CANCER RES

NAHTA R

Univ Texas, USA

pi 3-kinase p110 beta: a new target for antithrombotic therapy

137

2005

NATURE MED

JACKSON SP

Monash Univ, Australia

critical role for the p110 alpha phosphoinositide-3-oh kinase in growth and metabolic regulation

101

2006

NATURE

FOUKAS LC

Ludwig Inst Canc Res, England

identification and characterization of nvp-bez235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity

99

2008

MOL CANCER THER

MAIRA SM

Novartis Pharma AG, Switzerland

pharmacologic characterization of a potent inhibitor of class i phosphatidylinositide 3-kinases

86

2007

CANCER RES

RAYNAUD FI

Inst Canc Res, England

effective use of pi3k and mek inhibitors to treat mutant kras g12d and pik3ca h1047r murine lung cancers

70

2008

NATURE MED

ENGELMAN JA

Beth Israel Hosp, USA

essential roles of pi(3)k-p110 beta in cell growth, metabolism and tumorigenesis

61

2008

NATURE

JIA SD

Dana Farber Canc Inst, USA

a vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, sf1126, with antitumor and antiangiogenic activity

50

2008

CANCER RES

GARLICH JR

Aflac Canc Ctr & Blood Disorders Serv, USA

nvp-bez235, a dual pi3k/mtor inhibitor, prevents pi3k signaling and inhibits the growth of cancer cells with activating pi3k mutations

50

2008

CANCER RES

SERRA V

Vall Hebron Univ Hosp, Spain

the identification of 2-(1h-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (gdc-0941) as a potent, selective, orally bioavailable inhibitor of class ipi3 kinase for the treatment of cancer

50

2008

J MED CHEM

FOLKES AJ

Piramed Pharma, England

angiogenesis selectively requires the p110 alpha isoform of pi3k to control endothelial cell migration

49

2008

NATURE

GRAUPERA M

Canc Res UK London Res Inst, England

the p110 beta isoform of phosphoinositide 3-kinase signals downstream of g protein-coupled receptors and is functionally redundant with p110 gamma

45

2008

PROC NAT ACAD SCI USA

GUILLERMET-GUIBERT J

Queen Mary Univ London, England

phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mtor/phosphatidylinositol 3-kinase inhibitor nvp-bez235

35

2008

CANCER RES

EICHHORN PJA

Vall Hebron Univ Hosp, Spain

mutations in the phosphatidylinositol-3-kinase pathway predict for antitumor activity of the inhibitor px-866 whereas oncogenic ras is a dominant predictor for resistance

16

2009

CANCER RES

IHLE NT

MD Anderson Canc Ctr, USA

akt-independent signaling downstream of oncogenic pik3ca mutations in human cancer

14

2009

CANCER CELL

VASUDEVAN KM

Harvard Univ, USA

breast tumor cells with pi3k mutation or her2 amplification are selectively addicted to akt signaling

13

2008

PLOS ONE

SHE QB

Mem Sloan Kettering Canc Ctr, USA

 

RF ID

核心论文数

被引用篇数

总被引次数

平均出版年

是否为热点

8254

11

900

2120

2005.5

No

RF的关键词

oncogenic pi3k alpha mutations; phosphatidylinositol 3-kinase mutations identified; human breast cancers; human p110 alpha/p85 alpha complex elucidates; pik3ca mutations correlate

 

论文题目

被引

年份

刊名

第一作者

第一机构、国家

high frequency of mutations of the pik3ca gene in human cancers

687

2004

SCIENCE

SAMUELS Y

Johns Hopkins Univ, USA

mutation of the pik3ca gene in ovarian and breast cancer

245

2004

CANCER RES

CAMPBELL IG

Peter MacCallum Canc Ctr, Australia

phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic

225

2005

PROC NAT ACAD SCI USA

KANG SY

Scripps Res Inst, USA

mutant pik3ca promotes cell growth and invasion of human cancer cells

208

2005

CANCER CELL

SAMUELS Y

Johns Hopkins Univ, USA

pik3ca mutations correlate with hormone receptors, node metastasis, and erbb2, and are mutually exclusive with pten loss in human breast carcinoma

190

2005

CANCER RES

SAAL LH

Columbia Univ Coll Phys & Surg, USA

the pik3ca gene is mutated with high frequency in human breast cancers

161

2004

CANCER BIOL THER

BACHMAN KE

Johns Hopkins Univ, USA

pik3ca gene is frequently mutated in breast carcinomas and hepatocellular carcinomas

146

2005

ONCOGENE

LEE JW

Catholic Univ Korea, South Korea

cancer-specific mutations in pik3ca are oncogenic in vivo

95

2006

PROC NAT ACAD SCI USA

BADER AG

Scripps Res Inst, USA

the structure of a human p110 alpha/p85 alpha complex elucidates the effects of oncogenic pi3k alpha mutations

68

2007

SCIENCE

HUANG CH

Johns Hopkins Kimmel Canc Ctr, USA

mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit

61

2007

SCIENCE

MILED N

MRC, England

helical domain and kinase domain mutations in p110 alpha of phosphatidylinositol 3-kinase induce gain of function by different mechanisms

34

2008

PROC NAT ACAD SCI USA

ZHAO L

Scripps Res Inst, USA

 

RF ID

核心论文数

被引用篇数

总被引次数

平均出版年

是否为热点

11354

5

387

817

2005.0

No

RF的关键词

amino acid mtor/raptor signaling class-3 phosphatidylinosital 30h-kinase mediation; nutrient-regulated lipid kinase required; mammalian target; amino acid sufficiency; p70 s6 kinase

 

论文题目

被引

年份

刊名

第一作者

第一机构、国家

amino acids mediate mtor/raptor signaling through activation of class 3 phosphatidylinositol 30h-kinase

217

2005

PROC NAT ACAD SCI USA

NOBUKUNI T

Univ Utrecht, Netherlands

rheb binds and regulates the mtor kinase

198

2005

CURR BIOL

LONG X

Massachusetts Gen Hosp, USA

hvps34 is a nutrient-regulated lipid kinase required for activation of p70 s6 kinase

177

2005

J BIOL CHEM

BYFIELD MP

Albert Einstein Coll Med, USA

the tuberous sclerosis protein tsc2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses

115

2005

J BIOL CHEM

SMITH EM

Univ British Columbia, Canada

rheb binding to mammalian target of rapamycin (mtor) is regulated by amino acid sufficiency

110

2005

J BIOL CHEM

LONG XM

Harvard Univ, USA

 

RF ID

核心论文数

被引用篇数

总被引次数

平均出版年

是否为热点

13303

3

505

849

2004.0

No

RF的关键词

tsc/rheb/mtor/s6k cassette inappropriate activation induces irs1/2 depletion-insulin resistance-cell survival deficiencies; enhancing insulin sensitivity; insulin resistance; tsc1-2 tumor suppressor controls insulin-p13k signaling

 

论文题目

被引

年份

刊名

第一作者

第一机构、国家

absence of s6k1 protects against age- and diet-induced obesity while enhancing insulin sensitivity

362

2004

NATURE

UM SH

Friedrich Miescher Inst Biomed Res, Switzerland

the tsc1-2 tumor suppressor controls insulin-p13k signaling via regulation of irs proteins

278

2004

J CELL BIOL

HARRINGTON LS

Inst Canc Res, England

inappropriate activation of the tsc/rheb/mtor/s6k cassette induces irs1/2 depletion, insulin resistance, and cell survival deficiencies

209

2004

CURR BIOL

SHAH OJ

Salk Inst Biol Studies, USA

 

RF ID

核心论文数

被引用篇数

总被引次数

平均出版年

是否为热点

14863

3

315

405

2005.6

No

RF的关键词

ras/erk signaling; site-specific ribosomal protein s6 phosphorylation; mitogen-activated protein kinase-dependent s6 kinase pathway; protein synthesis; rapamycin-sensitive 5 ''-terminal oligopyrimidine mrna translation

 

论文题目

被引

年份

刊名

第一作者

第一机构、国家

s6k1(-/-)/s6k2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5 '-terminal oligopyrimidine mrna translation and reveal a mitogen-activated protein kinase-dependent s6 kinase pathway

226

2004

MOL CELL BIOL

PENDE M

INSERM 584, France

ribosomal protein s6 phosphorylation: from protein synthesis to cell size

118

2006

TRENDS BIOCHEM SCI

RUVINSKY I

Hebrew Univ Jerusalem, Israel

ras/erk signaling promotes site-specific ribosomal protein s6 phosphorylation via rsk and stimulates cap-dependent translation

61

2007

J BIOL CHEM

ROUX PP

Univ Montreal, Canada

 

RF ID

核心论文数

被引用篇数

总被引次数

平均出版年

是否为热点

9782

3

395

574

2006.0

Yes

RF的关键词

mtor inhibition induces upstream receptor tyrosine kinase signaling; rapamycin induces feedback activation; akt signaling; rapamycin inhibition; activates akt

 

论文题目

被引

年份

刊名

第一作者

第一机构、国家

mtor inhibition induces upstream receptor tyrosine kinase signaling and activates akt

318

2006

CANCER RES

O'REILLY KE

Mem Sloan Kettering Canc Ctr, USA

activation of akt and eif4e survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition

162

2005

CANCER RES

SUN SY

Emory Univ, USA

rapamycin induces feedback activation of akt signaling through an igf-1r-dependent mechanism

94

2007

ONCOGENE

WAN X

NCI, USA

 

RF ID

核心论文数

被引用篇数

总被引次数

平均出版年

是否为热点

7986

2

72

120

2008.0

Yes

RF的关键词

erk mapk signaling; hormone-refractory prostate cancer; mapk pathway activation; human cancer; pi3k-dependent feedback loop; preclinical mouse model

 

论文题目

被引

年份

刊名

第一作者

第一机构、国家

inhibition of mtorc1 leads to mapk pathway activation through a pi3k-dependent feedback loop in human cancer

77

2008

J CLIN INVEST

CARRACEDO A

77 Ave Louis Pasteur, USA

targeting akt/mtor and erk mapk signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model

43

2008

J CLIN INVEST

KINKADE CW

Columbia Univ, USA

 

RF ID

核心论文数

被引用篇数

总被引次数

平均出版年

是否为热点

12550

2

70

108

2008.0

Yes

RF的关键词

oncogenic cellular transformation; class ipi3k; pi3k/akt pathway; cancer; drug discovery

 

论文题目

被引

年份

刊名

第一作者

第一机构、国家

drug discovery approaches targeting the pi3k/akt pathway in cancer

65

2008

ONCOGENE

GARCIA-ECHEVERRIA C

Novartis Inst Biomed Res, Switzerland

class ipi3k in oncogenic cellular transformation

43

2008

ONCOGENE

ZHAO L

Scripps Res Inst, USA

 

 



https://blog.sciencenet.cn/blog-280034-687703.html

上一篇:研究热点与前沿:前列腺癌的流行病学、治疗方法与指南
下一篇:研究热点:E-钙粘素与β-连环素(β-catenin)相互作用
收藏 IP: 222.35.21.*| 热度|

1 苏光松

该博文允许注册用户评论 请点击登录 评论 (0 个评论)

数据加载中...
扫一扫,分享此博文

Archiver|手机版|科学网 ( 京ICP备07017567号-12 )

GMT+8, 2024-4-16 13:45

Powered by ScienceNet.cn

Copyright © 2007- 中国科学报社

返回顶部